关于我们
At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections.
- 网站
-
https://www.bioharmonytherapeutics.com
Bioharmony Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- New York,New York
- 类型
- 私人持股
- 创立
- 2016
地点
-
340 East 80th Street
US,New York,New York,10075